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The extensive circulation of Highly Pathogenic (HP) H5N1 Avian Inﬂuenza in Egypt in poultry since
2006 resulted in the emergence of distinct clades with the recent identiﬁcation of a further clade:
2.2.1.1. The aim of this study was to characterize for the ﬁrst time the antigenic proﬁle of an extensive
collection of genetically diverse Egyptian H5N1 HP viruses isolated between 2007 and 2010 applying
antigenic cartography and principal component analysis to serological data. We identiﬁed that Egyptian
H5N1 viruses have undergone signiﬁcant antigenic diversiﬁcation between 2007 and 2010 and two
distinct antigenic clusters co-circulated in 2010. Such clusters correlated with 2.2.1 and 2.2.1.1 clades,
showing for the ﬁrst time that the new emerging clade 2.2.1.1 is antigenically distinct. This study
highlights that the antigenic diversity of H5N1 HP Egyptian viruses may represent a potential challenge
for the development of an effective vaccination programme for animal and human health in Egypt.
& 2012 Elsevier Inc. All rights reserved.Introduction
Highly pathogenic avian inﬂuenza (HPAI) viruses of the H5N1
subtype descending from A/goose/Guangdong/1/96 lineage were
ﬁrst detected in Africa in 2006 (Chen et al., 2006). Egypt was the
second African country affected by H5N1 HPAI, which reported
cases of infection in poultry in early 2006. Initial attempts to
control the epidemics by implementing stamping out and move-
ment control measures were largely unsuccessful.
In March 2006 vaccination of poultry was authorized essentially
using inactivated vaccines derived from low pathogenic H5N2
Mexican or H5N1 Asian strains (Peyre et al., 2009). Notwithstanding
vaccination and other control measures applied, H5N1 HPAI infec-
tion continued to spread and became endemic in Egypt in 2008.
To June 7, 2012, H5N1 HPAI virus caused 168 human cases, of
which 60 were fatal (http://www.who.int/inﬂuenza/human_
animal_interface/avian_inﬂuenza/archive/en/index.html).
Clade 2.2.1 was introduced into Egypt and spread rapidly in
commercial and backyard ﬂocks (W H O/OIE/FAO, 2009). As a result
of the persistence and extensive circulation of H5N1 HPAI viruses in
Egypt, variant strains emerged evolving into distinct genetic
sub-clades (Cattoli et al., 2011a). Cattoli et al. (2011a) showed thatll rights reserved.
o).the majority of H5N1 HPAI viruses isolated between 2007 and 2010
fell within 2 main genetic groups, already identiﬁed by Balish et al.
(Balish et al., 2010) on a smaller data set, and identiﬁed as A and B
subclades. Amino acid substitutions in the receptor binding domain
(RBD), presence of distinct potential glycosylation sites, and differ-
ences in evolutionary rates were the characteristics that differen-
tiated the 2 genetic sub-clades that circulated between 2007 and
2010 in Egypt. Recently the WHO has identiﬁed 12 new H5N1
clades and the Egyptian sub-clade 2.2.1 was further split into a new
sub-clade 2.2.1.1, corresponding to genetic subclade B, indicating
further divergence of contemporary strains of H5N1 circulating in
Egyptian poultry (WHO/OIE/FAO H5N1 Evolution Working Group,
2012).
Our earlier study showed that an Egyptian H5N1 HPAI virus
from 2008 exhibited a low cross reactivity in haemagglutination-
inhibition (HI) tests against the Mexican vaccine seed strain (H5N2)
commonly used in Egypt, suggesting that signiﬁcant antigenic drift
occurred (Cattoli et al., 2011b). In this study, mutations at residues
74, 141, 140, 144, 162 (H5 numbering) in the RBD of a 2008 isolate
(A/chicken/Egypt/1709-6/2008) were identiﬁed as being responsi-
ble for the antigenic drift (Cattoli et al., 2011b). However, there is
still lack of systematic study of antigenic properties of H5N1 HPAI
Egyptian viruses in fact previous studies were based on the
characterization of few isolates which were isolated before 2010
(Balish et al., 2010; Grund et al., 2011). The goal of this study was to
evaluate for the ﬁrst time the antigenic characteristics of an
Fig. 1. Phylogenetic tree of the amino acid sequences of the HA gene of the Egyptian H5N1 HPAI viruses constructed by the neighbor-joining method. The viruses included
in the antigenic study are coloured according to the antigenic group they belong to. The numbers at each branch point represent bootstrap values and they were
determined by bootstrap analysis using 1000 replications. Scale bar¼0.04 amino acid substitutions/site.
Table 1
List of viruses under study, their abbreviations, genetic clade and the antigenic group. Viruses are coloured according to colours in the antigenic map./: no information
available.
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HPAI viruses by the antigenic cartography and principal component
analysis (PCA) and to assess the antigenic differences of clade 2.2.1
and 2.2.1.1 viruses that circulated in Egypt in 2007 and 2010. Such
systematic study will provide insights for development of more
effective vaccination programme in Egypt.Results
Genetic characterization of Egyptian H5N1 viruses
Analysis of the haemagglutinin (HA) phylogenetic tree identiﬁed
that viruses under study fall within the clade 2.2.1 or 2.2.1.1 (Fig. 1)
recently identiﬁed by the WHO (WHO/OIE/FAO H5N1 Evolution
Working Group, 2012). The H5N1 HPAI Egyptian viruses used in this
study and isolated in 2007 belong to clade 2.2.1 (Fig. 1), viruses
isolated in 2008 to clade 2.2.1.1 while viruses isolated in 2010
belong to both sub-clades: 2.2.1 and 2.2.1.1 (Fig. 1). Twenty-six
H5N1 HPAI viruses located through phylogenetic trees (marked in
colour) were selected as prototype viruses for antigenic character-
ization, and such a selection would expect to represent a systematic
picture for the antigenic proﬁle of Egyptian H5N1 HPAI viruses.Fig. 2. Inﬂuenza antigenic cartography for Egyptian H5N1 HPAI viruses from 2007
to 2010. Viruses in light blue belong to EG-antigen-A1 isolated in 2008, viruses in
dark blue belong to EG-antigen-A2 isolated in 2010, viruses in yellow belong to
EG-antigen-B1 group and viruses in red belong to EG-antigen-B2 group. In purple
is virus A/chicken/Egypt/3982-44/2010, in black virus A/chicken/Nigeria/4337-
343/2008 and in green virus A/chicken/Mexico/1994 (H5N2).Antigenic characterization of Egyptian H5N1 viruses
Antigenic cartography demonstrated for the ﬁrst time that
Egyptian H5N1 HPAI viruses can be intuitively separated into two
major antigenic clusters EG-antigen-A and EG-antigen-B, which
corresponded to clade 2.2.1 and 2.2.1.1 respectively. Speciﬁcally,
the tested H5N1 HPAI viruses: 1709-1/07, 1709-2/08, 1709-4/07,
1709-10/08, 4337-343/08, 1553-1/10, 1553-15/10, 3982-5/10,
3982-8/10 and 3982-9/10, all of which belong to genetic
clade 2.2.1, formed cluster EG-antigen-A (Fig. 2, Tables 1 and S1–2).
The other 15 Egyptian H5N1 HPAI viruses tested formed cluster
EG-antigen-B, and with the exception of strain 3982-44/2010
belonged to clade 2.2.1.1. Strain 3982-44 was shown to belong to
cluster EG-Antigen-B but genetically grouped with clade 2.2.1.
The average antigenic distances in EG-antigen-A and -B were 1.23
(standard deviation, 0.37) and 1.56 (standard deviation, 0.73)
units, respectively, and each unit corresponds to 2 log2 HI titre
(Table S2). The maximum distance between EG-antigen-A and
EG-antigen-B was 5.06 units (between strains 1553-1/2010 and
1553-26/2010), the minimum distance between EG-antigen-A
and EG-antigen-B was 1.63 units (between 1709-1/2008 and
3982-19/2010), and the average distance between EG-antigen-A
and EG-antigen-B was 3.57 units (Table S2). A student t-test
showed that the antigenic distances within each antigenic cluster
was signiﬁcantly different than those between the two identiﬁed
antigenic clusters by hierarchical clustering (po0.001).
Based on genetic data, we additionally performed the Principal
Component Analysis (PCA) analysis in order to assess the antigenic
evolution and trajectories. PCA showed that the Egyptian viruses test-
ed also formed two antigenic groups conﬁrming the antigenic carto-
graphy data, EG-antigen-A and EG-antigen-B, and that these groups
could be further separated into subgroups: EG-antigen-A1 and –A2,
and EG-antigen-B1 and B2 respectively (Figs. S1–S3). The viruses in
each antigenic subgroups are listed in Table 1: EG-antigen-A1
comprised viruses isolated in 2007 and 2008 (1709-1/2007; 1709-
2/2008; 1709-4/2007; and 1709-10/2008; 4337-343/07) and EG-
antigen-A2 comprised ﬁve viruses isolated in 2010 (1553-1/2010,
1553-13/2010, 3982-5/2010, 3982-8/2010, 3982-9/2010); EG-
antigen-B1 comprised 2 viruses isolated in 2008 (strain 1709-5/
2008 and 1709-6/2008) and one virus isolated in 2010 (strain
3982-19/2010), and EG-antigen-B2 comprised viruses isolated onlyin 2010 (Table 1, Figs. 2 and S2). The average distances and mean
values of each of these subgroups are shown in Table S2.
The MN assay conﬁrmed the HI data and showed that anti
group A sera did not neutralize group B viruses and vice versa.
The MN assay also conﬁrmed that the 3982-44/10 virus does not
belong to EG-antigen-A because no neutralization was observed
with homologous antisera to this group (Table S3).
Antigenic cartography demonstrated that the vaccine strain
A/chicken/Mexico/1994 (H5N2) was antigenically distinct from
the H5N1 Egyptian viruses, including both antigenic clusters EG-
antigen-A and -B. However, A/chicken/Mexico/1994 (H5N2) was
antigenically closer to the EG-antigen-A than the EG-antigen-B
(Fig. 2, Table S2).
A/chicken/Nigeria/4337-343/2008, the earlier strain intro-
duced into Africa was located in antigenic cluster A, which
included most of the 2008 isolates. This observation was
validated with the HI assay. With reference to the spatial
distribution of viruses (Fig. 3 and Table 1), available informa-
tion is fragmentary and precluded making conclusions on the
prevalence of EG-antigen-A or B viruses in Egypt. Instead, both
EG-antigen-A and B were co-circulating at the same time in
Egypt, e.g. in year 2008, and 2010. The geographic distribut-
ions of EG-antigen-A or B did not show relevant associa-
tions between geographic locations and antigenic clusters,
either (Fig. 3).
Molecular characterization of antigenic groups
A total of 20 amino acid (aa) differences were observed in the
antigenic sites of the HA gene of viruses under study. Seven of the
differences were detected in the antigenic site A, 9 in the antigenic
site B, 1 in the antigenic site D, 1 in the antigenic site E and
2 falling outside these antigenic sites (Table 2). Thirteen of these
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patterns among the antigenic subgroups identiﬁed through anti-
genic cartography and included residues 151 (155, H3 numbering,
antibody binding site B in H3), 154 (158, B), 156 (160, B), 162 (166,
B), 190 (194, B), 120 (125, A), 129 (133, A), 140 (144, A), 141 (145,
A), 226 (230, D), 74 (82, E), 97 (104), and 144 (148) (Table 2). The
aa mutation, observed at position 144 near the 130 loop, was
involved in the vaccine drift of 1709-6/2008 strain (Cattoli et al.,
2011b). Positions 120, 140, 141, 154, 156 were conﬁrmed to affect
the antigenicity of H5N1 HPAI viruses (Cai et al., 2010). The
majority of antigenic cluster EG-Antigen-B (clade 2.2.1.1) viruses
presented the following aa mutations against EG-Antigen-A:Fig. 3. Geographical location of H5N1 HPAI antigenic clusters in Egypt.
Table 2
Amino acid changes in the HA molecule of H5N1 HPAI Egyptian viruses under study. T
group and genetic clade they belong to -:deletion.D97N, P74S, F144Y, S141P, M226V and A156T. The differences
between EG-Antigen-A1 and EG-Antigen-A2 can be found in
residues 120, 151 and 154. The differences between EG-Antigen-
B1 and EG-Antigen-B2 were less apparent. The majority of viruses
belonging to the antigenic clusters B1 and B2 showed differences
in residues 129, 154, 156, 162, and 190. This indicated the
complication of antigenic diversity in Egyptian H5N1 viruses.
Further experiments are required to conﬁrm the role of each
residue in affecting antigenic properties for these Egyptian H5N1
viruses.
It is interesting that A/chicken/Egypt/3982-44/2010 (H5N1)
has the residues similar to those in EG-Antigen-A, although
antigenically this virus is more similar to those viruses located
in EG-Antigen-B . Genetically this virus belongs to clade 2.1.1 as
well. Further study is required to identify the unique features
determining the antigenicity of this virus.Discussion
In this study we used a serological approach to cluster H5N1
HPAI viruses isolated in Egypt between 2007 and 2010. The
application of the antigenic cartography and PCA highlighted
the similarity and diversity on a representative and wide-
ranging collection of viruses. This study represents a ﬁrst unique
evidence of the existence of distinct antigenic clusters among
Egyptian viruses circulating in 2010. In addition we were able to
speculate on the evolution of antigenic clusters identiﬁed.
Through the antigenic cartography approach, in this study we
have identiﬁed inter and intra clade antigenic differences of
viruses belonging to clades 2.2.1 and 2.2.1.1. Inter and intra clade
cross-reactivity were already studied for 9 clades including clade
2.2 (Ducatez et al., 2011).
Although each antigenic cluster was further divided in two
sub-clusters, the average distance within each sub-cluster (A1-2he H5 and H3 numbering are given. Viruses are listed according to the antigenic
M.S. Beato et al. / Virology 435 (2013) 350–356354and B1-2) calculated trough the antigenic cartography approach is
different. Viruses of EG-antigen-A1 and 2 have a minor antigenic
distance (minimum and maximum) than viruses of EG-antigen-B1
and 2. The evidence that the 1709-6/2008 virus clusters in the EG-
antigen-B1 group, together with 2010 isolates, conﬁrmed a pre-
vious study (Cattoli et al., 2011b) that identiﬁed this virus as an
antigenic variant compared to 1709-1/07 isolate (EG-antigen-A1).
There is one strain (A/chicken/Egypt/3982-44/2010), which
behaved differently from an antigenic viewpoint. Although this
virus belonged to 2.2.1 clade, it grouped with anti EG-antigen-B
viruses by HI. However phylogenetic analysis of this virus did not
show any peculiar aa mutations at the antigenic sites which could
be responsible for such difference. The lack of detection of viruses
similar in the antigenic and genetic properties to that one might
be related to gaps in surveillance or they have been supplanted by
the new clade 2.2.1.1. Performing studies on additional viruses
may verify the hypothesis as to whether this virus represents a
single case or a representative member of a different group.
In addition, PCA analysis suggested that from an antigenic
point of view the EG-antigen-A2 and the EG-antigen-B clusters
evolved from the EG-antigen-A1 viruses formed by earlier viruses
and they may represent the antigenic ancestor viruses. Thus it
seems that viruses followed two different antigenic evolutionary
trajectories from 2007 to 2010; one trajectory resulted in the
EG-antigen-A2 group and the other in the EG-antigen-B cluster.
The EG-antigen B1 appeared in between of EG-antigen-A1 and B2
suggesting that already in 2008 the Egyptian H5N1 viruses were
subjected to an antigenic differentiation.
Further the PCA showed that sera A/chicken/Egypt/1709-6/
2008 cross-reacted well against both antigenic clusters. This was
conﬁrmed by the MN assay, and suggests that vaccine production
may induce antibodies, which are cross-reactive and neutralizing
in vitro against EG-antigen-A and B viruses.
The ﬁnding that the Mexican virus is more antigenically
related to EG-antigen-A than B may indicate that the continued
circulation in immunized and partially immunized poultry popu-
lation of clade 2.2.1 was the driven force for their antigenic
evolution as suggested by the higher antigenic distance of
EG-antigen-B viruses than A, from the Mexican strain. However
in Egypt several vaccine preparations are in use (Peyre et al.,
2009) suggesting that the Egyptian viruses are not under a
uniform immunological pressure. Whether the higher antigenic
distance of the Mexican strain and the EG-antigen-B viruses may
be indicative of reduced vaccine efﬁcacy against this antigenic
cluster, cannot be stated without performing in vivo tests.
However, previous studies (Terregino et al., 2010) showed that
the low cross reactivity of H5N2 Mexican strain with 2008
Egyptian strains did not predict the clinical and virological
protection achieved following challenge with the 1709-6/2008
strain or genetically related viruses.
Although in vitro mutagenesis was not carried out to assess
the real impact of aa changes observed between the 2 clades,
most probably, as already shown (Cattoli et al., 2011b) the
mutations in positions 74, 104, 140, 141 and 144 may be
responsible for the antigenic differences of clades 2.2.1 and
2.2.1.1. As reported previously the P74S and R140G mutations
in clade 2.2.1.1 virus resembled the antigenicity of a clade 2.2.1
virus suggesting the key role of this aa changes for the inter clade
antigenic diversity (Cattoli et al., 2011b).
The M226V mutation was reported to occur in a unexposed
part of the HA molecule and to not affect the antigenic proﬁle of
viruses 1709-1/07 (clade 2.2.1) and 1709-6/08 (clade 2.2.1.1):
however, our study showed that this mutation is conserved
among all clade 2.2.1.1 viruses under study suggesting this
change may be advantageous for viral antigenic ﬁtness of clade
2.2.1.1 strains. With reference to mutation N97D, which is presentin all clade 2.2.1.1 viruses and not included in any antigenic site,
we can speculate that such change may be the result of a vaccine
pressure as for the P74S mutation (Cattoli et al., 2011b). This is
suggested by the presence of D aa in position 97 in the Mexican
vaccine seed strain (H5N2).
A conserved aa mutation at position 151 in the antigenic site B
was detected between EG-antigen-A1 and 2 viruses which
together with aa changes in position 120 (antigenic site A) may
be responsible of this sub-clustering . Few aa mutations that
differentiated EG-antigen-B1 and 2 viruses were detected most
probably due to the low number (3) of EG-antigen-B1 viruses
under study. However two of 3 EG-antigen-B1 viruses (1709-5/08
and 1709-6/08) shared the N154D, T156A (antigenic site B) and
L129S (antigenic site A) aa mutations with EG-antigen-A1 and/or
2 viruses but not with EG-antigen-B2 viruses. These 2 viruses may
represent an evolutionary snapshot from EG-antigen-A to B or
from clade 2.2.1 to 2.2.1.1.Conclusions
Through a systematic study of the antigenic proﬁling of Egyptian
H5N1 HPAI viruses, we have shown for the ﬁrst time that
substantial antigenic differences exist inter and also intra clades.
Our results demonstrated that multiple antigenic clusters
co-circulated in Egypt in 2010, even in the same Egyptian province,
as having generating the challenges in vaccination programme and
pandemic preparedness. The antigenic evolution of the Egyptian
H5N1 HPAI viruses followed a temporal pattern. We were also able
to speculate on the impact of aa changes observed on the antigenic
difference noticed and on the evolution of antigenic clusters.
However further studies are necessary to elucidate the speciﬁc role
of each aa mutations in the Egyptian H5N1 viruses. Data presented
herein conﬁrm that newly recognized clade 2.2.1.1 shows a distinct
antigenic proﬁle from 2.2.1 viruses. This study can be considered as
ﬁrst step for a more harmonized approach to study the antigenic
characteristics of Egyptian H5N1 HPAI viruses. The results of this
investigation emphasize the need to monitor constantly the genetic
and antigenic evolution of H5N1 viruses in endemic countries such
as Egypt in order to make educated decisions on vaccine candidates
for humans and animals.Materials and methods
Phylogenetic analysis
The phylogenetic analysis was used to select representative
viruses to carry out the antigenic analysis and to identify muta-
tions which may be involved in the antigenic diversiﬁcation of
viruses under study.
Sequences of the HA gene of ﬁfty H5N1 HPAI viruses isolated in
Egypt between 2007 and 2010, previously generated (Cattoli et al.,
2011a), were used to construct a phylogenetic tree. Sequences of
viruses under study were aligned and compared with some
representative publicly available H5N1 HPAI sequences of viruses
from Egypt.
The sequences were deposited into GenBank with accession
numbers EU17849, EU17851, EU17853, EU17855, EU17857,
CY047979, CY020645; CY016899; AY497096; and in the GISAID
database under accession numbers: EPI81469–EPI81472 ; EPI81478–
EPI81505 ; EPI20904; EPI156750; EPI156776; EPI156731;
EPI287355; EPI81506–EPI81507 ; EPI20912.
For the HA gene, maximum likelihood (ML) tree was estimated
using the best-ﬁt general time-reversible (GTR)þ IþG4 model of
nucleotide substitution using PAUP* (Wilgenbusch and Swofford,
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composition, gamma distribution of the rate variation among
sites (with four rate categories, G4), and proportion of invariant
sites (I) were estimated directly from the data using MODELTEST
V.3.7 (Posada and Crandall, 1998). A bootstrap resampling process
(1000 replications) using the neighbor joining (NJ) method was
used to assess the robustness of individual nodes of the phylo-
geny, incorporating the ML substitution model deﬁned above.
Viruses included in the antigenic analysis
A total of 26 H5N1 HPAI viruses isolated from poultry were
selected according to the phylogenetic analysis (Table 1). Four
H5N1 viruses belonging to genetic clade 2.2.1 and two to clade
2.2.1.1 were isolated in 2008. The remaining H5N1 viruses were
isolated during 2010: 6 belonged to clade 2.2.1 and 12 to clade
2.2.1.1. One H5N1 virus used in this study was isolated in 2007 (A/
chicken/Egypt/1709-1/2007) and belonged to clade 2.2.1. In addi-
tion, A/chicken/Mexico/1994 (H5N2) and A/chicken/Nigeria/4337-
343/2008 (H5N1 HPAI clade 2.2) were included. A/chicken/Mexico/
1994 (H5N2) was included as it is one of the vaccine strain widely
used in commercial poultry in Egypt (Peyre et al., 2009).
Viruses were grown in 10–11 -day-old Speciﬁc Pathogen Free
(SPF) chicken embryonating eggs and inactivated with 0.05% (v/v)
of beta-propiolactone . Information on viruses (i.e. genetic clade,
area of isolation) is listed in Table 1.
Antisera
Antisera were produced in SPF chickens using representative
H5N1 HPAI viruses of genetic clades 2.2.1 and 2.2.1.1, isolated in
2008 and 2010. The following viruses were used to immunize
chickens without adjuvant: A/chicken/Egypt/1553-1/2010, clade
2.2.1 (1553-1/10); A/chicken/Egypt/1553-15/2010, clade 2.2.1
(1553-15/10); A/chicken/Egypt/1553-2/2010, clade 2.2.1.1 (1553-
2/10) and A/chicken/Egypt/1553-13/2010, clade 2.2.1.1 (1553-13/
10). Groups of 10 chickens per virus were used. Five chickens were
injected intravenously and ﬁve intramuscularly (without adjuvant)
with 0.5 ml undiluted inactivated virus. Chickens were boosted
once, 2 weeks after initial injection with 0.5 ml undiluted virus. A
booster was necessary to achieve a minimum HI titre of 5log 2 to
carry out HI tests. Inactivated viruses used to immunized birds
showed haemagglutinating titres between 6 and 7log 2. Serum
samples were collected 3 weeks after the second immunization.
Blood was collected and stored per individual bird. Sera against
viruses A/chicken/Egypt/1709-6/2008, clade 2.2.1.1 (1709-6/08)
and A/chicken/Mexico/1994 (H5N2) were used as control and
produced by intramuscular injection of 0.5 ml inactivated viral
antigens emulsiﬁed with adjuvant (ISA 70VG, SEPPIC, France). A
total of 43 chicken serum samples were collected but only 40 were
used to carry out the cross HI tests as 3 chickens did not
seroconvert. All animals were handled in strict accordance with
the relevant national animal care guidelines.
Haemaglutination inhibition and microneutralization tests
The HI test was carried out according to OIE guidelines (OIE,
2010). Serum samples were tested individually, resulting in 40 HI
titre values for each virus isolate. The antigenic dataset consisted
of a table of 40 chicken sera by 26 viruses with 1040 individual HI
measurements expressed as log 2.
The serum neutralizing activity was assessed by a standard
microneutralization test (MN) assay performed as previously
described (Rowe et al., 1999). Avian sera were treated with a
receptor destroying enzyme (RDE) before use and heat inacti-
vated at þ56 1C for 30 min. Anti 1709-6/08 (clade 2.2.1.1), antiMexican H5N2, anti 1553-1/10 (clade 2.2.1) and anti 1553-13/10
(clade 2.2.1.1) sera were used in the MN assay to test their
neutralizing activity against the homologous and 3982-44/10
viruses. The initial starting dilution of all sera was 1:80.
Antigenic cartography construction
The antigenic proﬁling of the 26 selected H5N1 HPAI viruses
was analyzed using AntigenMap (http://sysbio.cvm.msstate.edu/
AntigenMap). AntigenMap was developed for antigenic cartogra-
phy construction. AntigenMap calculated antigenic distance
based HI data by integrating low rank matrix completion and
multiple dimensional scaling (Cai et al., 2010). The data normal-
ization was performed as described elsewhere (Ducatez et al.,
2011). The low rank matrix completion can not only help recover
the missing values in HI data but also reduce noises in HI data.
In this study, we utilized also the PCA, which derived the
relationships among viruses from the HI data. PCA provided an
additional method to conﬁrm the antigenic relationship in anti-
genic cartography (see supplementary information).Disclaimer
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